Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Nelson DR, Koymans L, Kamataki T, et al.: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996, 6:1–42.
2. Whitlock JP: Induction of cytochrome P4501A1. Annual Rev Pharmacol Toxicol 1999, 39:103–125. This recent comprehensive review summarizes our current understanding of the regulation of CYP1A1. Implications for enhanced carcinogen activation and cancer susceptibility are discussed.
3. Cascorbi I, Brockmöller J, Mrozikiewicz PM, et al.: Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996, 56:3961–3966.
4. Iba MM, Scholl H, Fung J, et al.: Induction of pulmonary CYP1A1 by nicotine. Xenobiotica 1998, 28:827–843. Extensive animal data are presented to support the classification of nicotine as a potent inducer of CYP1A1. In addition to further elucidating the mechanism by which cigarette smoke induces CYP1A1, the results from this study imply that nicotine replacement products could increase cancer risk.
5. Benet LZ, Kroetz DL, Sheiner LB: Pharmacokinetics. In Goodman and Gilman’s Pharmacological Basis of Therapeutics, edn 9. Edited by Hardman LG, Goodman Gilman A, Limbird LE. New York: McGraw-Hill; 1996:3–27.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献